VM110 in Detection of Microscopic Tumors: A Phase I Study

Summary

A laproscopic imaging tecgnology that uses a synthetic agent to detect ovarian and pancreatic cancers at an early stage so that patients can get treatment early and prevent the disease from advancing to late stage leading to fatality or recurrence.

Timeline

Start

2017-10-12

Primary completion

2019-07-10

Completion

2020-04-03

Outcome

Outcome not reported

Stopped (Enrollment): “Slow accrual”

Drugs

Indications